Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Efficacy and Safety of GTR in Comparison to Copaxone® (GATE)
Safety study of BIIB033 in subjects with multiple sclerosis
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
ACTRIMS-ECTRIMS 2014 -- Day 1, morning
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
iConquerMS™ Advances Patient-Driven Multiple Sclerosis Research
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists.
Foreseeing the Future?
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Development of oral immunomodulatory agents in the management of multiple sclerosis.
Episode 63 with Dr. Helen Tremlett on studying sun exposure in MS
ECTRIMS 2013 Day 3
LINGO-1 negatively regulates myelination by oligodendrocytes.
Immunomodulatory agents and risk of postpartum multiple sclerosis relapses.
Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica: Multicenter Study of Treatment Efficacy.
Gordon Research Conference: Myelin
TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
MS Patient, Ph.D.: Can We Separate Anxiety and Gender in MS?
Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis.
Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Ocrelizumab Bests Interferon in Relapsing-Remitting MS
MS Research Roundup: January 17, 2014
Untangling TNF Trouble
Pages
« first
‹ previous
…
41
42
43
44
45
46
47
48
49
…
next ›
last »
